Farhad Paylakhi

Farhad (Seyyedhassan) Paylakhi is a highly experienced professional in the field of molecular genetics and gene therapy, currently serving as Co-founder and Vice President of R&D at 64x Bio since May 2023, while also owning and consulting for DelGene Z LLC. Prior experience includes roles as Director at Resilience and Senior Scientist at BioMarin Pharmaceutical Inc., where contributions included significant advancements in AAV process development and analytical leadership. Farhad's academic background includes a PhD and MSc from Tarbiat Modares University, where extensive research led to the publication of multiple peer-reviewed articles during a tenure as Assistant Professor at Damghan University and a postdoctoral fellowship at UCSF focusing on ocular growth regulation.